Literature DB >> 16697217

Intrathecally infused antibodies against Nogo-A penetrate the CNS and downregulate the endogenous neurite growth inhibitor Nogo-A.

Oliver Weinmann1, Lisa Schnell, Arko Ghosh, Laura Montani, Christoph Wiessner, Thierry Wannier, Eric Rouiller, Anis Mir, Martin E Schwab.   

Abstract

Neutralizing antibodies against the neurite growth inhibitory protein Nogo-A are known to induce regeneration, enhance compensatory growth, and enhance functional recovery. In intact adult rats and monkeys or spinal cord injured adult rats, antibodies reached the entire spinal cord and brain through the CSF circulation from intraventricular or intrathecal infusion sites. In the tissue, anti-Nogo antibodies were found inside Nogo-A expressing oligodendrocytes and neurons. Intracellularly, anti-Nogo-A antibodies were colocalized with endogenous Nogo-A in large organels, some of which containing the lysosomal marker cathepsin-D. This suggests antibody-induced internalization of cell surface Nogo-A. Total Nogo-A tissue levels in spinal cord were decreased in intact adult rats following 7 days of antibody infusion. This mechanism was confirmed in vitro; cultured oligodendrocytes and neurons had lower Nogo-A contents in the presence of anti-Nogo-A antibodies. These results demonstrate that antibodies against a CNS cell surface protein reach their antigen through the CSF and can induce its downregulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16697217     DOI: 10.1016/j.mcn.2006.03.007

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  22 in total

1.  Hippocampal expression of myelin-associated inhibitors is induced with age-related cognitive decline and correlates with deficits of spatial learning and memory.

Authors:  Heather D Vanguilder; Georgina V Bixler; William E Sonntag; Willard M Freeman
Journal:  J Neurochem       Date:  2012-02-10       Impact factor: 5.372

2.  Amino-Nogo-A antagonizes reactive oxygen species generation and protects immature primary cortical neurons from oxidative toxicity.

Authors:  Y-J Mi; B Hou; Q-M Liao; Y Ma; Q Luo; Y-K Dai; G Ju; W-L Jin
Journal:  Cell Death Differ       Date:  2012-01-20       Impact factor: 15.828

3.  Neutralization of Nogo-A enhances synaptic plasticity in the rodent motor cortex and improves motor learning in vivo.

Authors:  Ajmal Zemmar; Oliver Weinmann; Yves Kellner; Xinzhu Yu; Raul Vicente; Miriam Gullo; Hansjörg Kasper; Karin Lussi; Zorica Ristic; Andreas R Luft; Mengia Rioult-Pedotti; Yi Zuo; Marta Zagrebelsky; Martin E Schwab
Journal:  J Neurosci       Date:  2014-06-25       Impact factor: 6.167

Review 4.  Rewiring the spinal cord: Direct and indirect strategies.

Authors:  Maria Teresa Dell'Anno; Stephen M Strittmatter
Journal:  Neurosci Lett       Date:  2016-12-19       Impact factor: 3.046

5.  Nogo-A is a negative regulator of CNS angiogenesis.

Authors:  Thomas Wälchli; Vincent Pernet; Oliver Weinmann; Jau-Ye Shiu; Anna Guzik-Kornacka; Guillaume Decrey; Deniz Yüksel; Hannah Schneider; Johannes Vogel; Donald E Ingber; Viola Vogel; Karl Frei; Martin E Schwab
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-26       Impact factor: 11.205

6.  Intrathecal treatment with anti-Nogo-A antibody improves functional recovery in adult rats after stroke.

Authors:  Shih-Yen Tsai; Tiffanie M Markus; Ellen M Andrews; Joseph L Cheatwood; April J Emerick; Anis K Mir; Martin E Schwab; Gwendolyn L Kartje
Journal:  Exp Brain Res       Date:  2007-08-24       Impact factor: 1.972

7.  Widespread brain distribution and activity following i.c.v. infusion of anti-β-secretase (BACE1) in nonhuman primates.

Authors:  Daniela Bumbaca Yadav; Janice A Maloney; Kristin R Wildsmith; Reina N Fuji; William J Meilandt; Hilda Solanoy; Yanmei Lu; Kun Peng; Blair Wilson; Pamela Chan; Kapil Gadkar; Andrew Kosky; Marisa Goo; Ann Daugherty; Jessica A Couch; Thomas Keene; Karen Hayes; Lisa Jungbauer Nikolas; Deanna Lane; Robert Switzer; Eric Adams; Ryan J Watts; Kimberly Scearce-Levie; Saileta Prabhu; Lisa Shafer; Deepak R Thakker; Keith Hildebrand; Jasvinder K Atwal
Journal:  Br J Pharmacol       Date:  2017-10-06       Impact factor: 8.739

Review 8.  Spinal cord injury: time to move?

Authors:  Serge Rossignol; Martin Schwab; Michal Schwartz; Michael G Fehlings
Journal:  J Neurosci       Date:  2007-10-31       Impact factor: 6.167

9.  Anti-Nogo-A antibody treatment promotes recovery of manual dexterity after unilateral cervical lesion in adult primates--re-examination and extension of behavioral data.

Authors:  Patrick Freund; Eric Schmidlin; Thierry Wannier; Jocelyne Bloch; Anis Mir; Martin E Schwab; Eric M Rouiller
Journal:  Eur J Neurosci       Date:  2009-03       Impact factor: 3.386

10.  Nogo-a regulates neural precursor migration in the embryonic mouse cortex.

Authors:  Carole Mathis; Aileen Schröter; Michaela Thallmair; Martin E Schwab
Journal:  Cereb Cortex       Date:  2010-01-21       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.